Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
This in-person conference is tailored for healthcare professionals dedicated to improving service development and integrating cutting-edge treatment methodologies in Haemato-Oncology.
Why attend?
Refresh your knowledge with accessible, scientifically grounded, and practical insights from leading experts.
Gain the tools and understanding needed to enhance service delivery, effectively manage symptoms, and support your team in a rapidly evolving clinical field.
Benefit from a multi-professional approach that emphasises teamwork and trust-wide integration.
Key topics
Latest treatments in haemato-oncology, including bispecifics, CAR-T therapy, and red cell transplants
Strategies for aligning service development with recent advancements
Development and practical application of bispecific antibodies
Symptom assessment and management for patients on bispecifics
Effective management approaches for CAR-T cell therapy patients
Achieving comprehensive MDT and trust-wide assessment
Don’t miss this opportunity to learn about new treatments and guidance and network with peers.
–
